Nov. 13, 2015:

Big Ten Cancer Research Consortium members understand it takes the whole team to win the battle against cancer. By leading efforts to enhance diversity, members and consortium leadership are working hard to tackle disparities in clinical trial participation. Last month Susan Goodin, executive officer of the Big Ten Cancer Research Consortium, had the opportunity to be a panelist at a forum on clinical trial diversity in Chicago.

Also in this month’s edition of Across the Consortium, we highlight the many ways our members are pushing the boundaries of science and technology in order to improve diagnosis, treatment, and other cancer related experiences.

Read More

Oct. 16, 2015:

Breakthroughs and breakaways: these are the exciting results of the Big Ten Cancer Centers’ collective fight against cancer. In this month’s edition of Across the Consortium, we recount the innovative breakthroughs of member institutions asking – and answering – big questions in oncology. Non-drug treatments, cutting-edge device development, and genetic analyses are just a few highlights. We also glean inspiration from the breakaway performances of Big Ten research leaders achieving new milestones and paving the way for the leaders of tomorrow. As the impact of senior faculty deepens, new training programs broaden the pool of future talent.

Read More

Sept. 18, 2015:

Member institutions of the Big Ten Cancer Research Consortium consistently lay the foundations for ground-breaking cancer research – in more ways than one! Across the consortium, members are breaking ground for a new research facility and advancing research through new approaches, new business ventures, and new discoveries. This month, we highlight innovation, recognize the receipt of prestigious grants, and celebrate the “ground breaking” being done – Across the Consortium!

Read More

Aug. 25, 2015:

Ultimate success in the fight against cancer requires advances at every stage. In this month’s edition of Across the Consortium, we celebrate victories at a number of critical stages in cancer research. Through thesis formation to diverse funding acquisition, opportunities for new programs arise, leading to further innovation, collaboration, and success.

Read More

July 16, 2015:

As the Big Ten Cancer Research Consortium (Big Ten CRC) faces off against complex, diverse cancers, our member institutions continue to leverage their unique strengths to volley game-changing breakthroughs. This month’s edition of Across the Consortium highlights recent advancements on the fields of research, funding, diagnosis, and treatment.

Read More

June 22, 2015:

This month, we draw attention to significant milestones and achievements at Big Ten Cancer Research Consortium (Big Ten CRC) member institutions: From the launch of the Big Ten CRC’s first clinical trial at the University of Illinois, to Dr. Max Wicha’s appointment to the National Cancer Advisory Board by President Obama; from significant funding to Big Ten CRC institutions by the Howard Hughes Medical Institute and the American Cancer Society, to the University of Nebraska’s partnership with IBM on the Watson Genomic Analytics program. We celebrate the groundbreaking of the Michigan State University Grand Rapids Research Center, and we highlight advances in research Across the Consortium.
Read More

April 17, 2015:

Each month, the Big Ten Cancer Research Consortium highlights advances in research and treatment led by our member institutions. Following are recent developments across the consortium:

Read More

March 25, 2015:

Big Ten cancer centers continue to make advances in cancer research and treatment. In this edition of Across the Consortium, we highlight research from our member institutions in colorectal, prostate, brain, ovarian, and other cancers; we celebrate the generosity of the Hirair and Anna Hovnanian Foundation, whose gift to the University of Michigan Comprehensive Cancer Center will help researchers establish the world’s most comprehensive genomic analysis of adrenal cancers; we see once again what is possible when state legislatures get behind cancer research; and we applaud our member institutions and investigators who have achieved recent accolades and honors, of which only a few are mentioned in this article.

Read More

Feb. 16, 2015:

Insightful questions lie at the root of every advance in cancer research and improvement in patient care: What causes cells, as they become cancerous, to switch from aerobic metabolism to glycolysis, which does not require oxygen? How might a more complete understanding of a tumor’s “onco-ecosystem” change the way we treat disease? Where will precision medicine and immunotherapy take us in the future? These are just a few of the questions currently being explored at Big Ten cancer centers.

Read More

Jan. 19, 2015:

We begin a new year with recent highlights from each member institution of the Big Ten Cancer Research Consortium. From new discoveries in our understanding of RNAs to re-emerging ideas about Vitamin C; from initiatives that focus on our communities at home to those that stretch across continents, Big Ten cancer centers continue to innovate and inspire. Here’s to a promising new year across the consortium!

Read More